Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2019, Article ID 5267025, 7 pages
https://doi.org/10.1155/2019/5267025
Research Article

Diabetes Mellitus, Nonalcoholic Fatty Liver Disease, and Conjugated Linoleic Acid (Omega 6): What Is the Link?

1Internal Medicine Department, Faculty of Medicine, Cairo University, Egypt
2Biochemistry Department, Faculty of Medicine, Cairo University, Egypt

Correspondence should be addressed to Naglaa M. Elsayed; moc.oohay@1dhmaalgan

Received 7 July 2018; Revised 5 March 2019; Accepted 18 March 2019; Published 8 April 2019

Academic Editor: Antonio Brunetti

Copyright © 2019 Mona Hegazy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. K. Ching, Fatty Acids in Foods and Their Health Implications, CRC Press, 2nd edition, 2007.
  2. T. R. Dhiman, G. R. Anand, L. D. Satter, and M. W. Pariza, “Conjugated linoleic acid content of milk from cows fed different diets,” Journal of Dairy Science, vol. 82, no. 10, pp. 2146–2156, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Bissonauth, Y. Chouinard, J. Marin, N. Leblanc, D. Richard, and H. Jacques, “The effects of t10,c12 CLA isomer compared with c9,t11 CLA isomer on lipid metabolism and body composition in hamsters,” The Journal of Nutritional Biochemistry, vol. 17, no. 9, pp. 597–603, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Dey and K. Chandrasekaran, “Hyperglycemia-induced changes in liver: in vivo and in vitro studies,” Current Diabetes Reviews, vol. 5, no. 2, pp. 67–78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Fabbrini, S. Sullivan, and S. Klein, “Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications,” Hepatology, vol. 51, no. 2, pp. 679–689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. D. N. Amarapurkar and N. D. Patel, “Clinical spectrum and natural history of non-alcoholic steatohepatitis with normal alanine aminotransferase values,” Tropical Gastroenterology, vol. 25, no. 3, pp. 130–134, 2004. View at Google Scholar
  7. J. K. Reddy and M. Sambasiva Rao, “Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 290, no. 5, pp. G852–G858, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Diraison, P. Moulin, and M. Beylot, “Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease,” Diabetes & Metabolism, vol. 29, no. 5, pp. 478–485, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Ronis, Y. Chen, C.-H. Jo, P. Simpson, and T. M. Badger, “Diets containing soy protein isolate increase hepatic CYP3A expression and inducibility in weanling male rats exposed during early development,” The Journal of Nutrition, vol. 134, no. 12, pp. 3270–3276, 2004. View at Publisher · View at Google Scholar
  10. H.-L. Huang, W.-Y. Lin, L.-T. Lee, H.-H. Wang, W.-J. Lee, and K.-C. Huang, “Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects,” Obesity Surgery, vol. 17, no. 11, pp. 1457–1463, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Abenavoli, N. Milic, L. di Renzo, T. Preveden, M. Medić-Stojanoska, and A. de Lorenzo, “Metabolic aspects of adult patients with nonalcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 22, no. 31, pp. 7006–7016, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. “EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease,” Journal of Hepatology, vol. 64, no. 6, pp. 1388–1402, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. A. M. Zivkovic, J. B. German, and A. J. Sanyal, “Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease,” The American Journal of Clinical Nutrition, vol. 86, no. 2, pp. 285–300, 2007. View at Publisher · View at Google Scholar
  14. A. Ferramosca and V. Zara, “Modulation of hepatic steatosis by dietary fatty acids,” World Journal of Gastroenterology, vol. 20, no. 7, pp. 1746–1755, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Ricci, R. Longo, E. Gioulis et al., “Noninvasive in vivo quantitative assessment of fat content in human liver,” Journal of Hepatology, vol. 27, no. 1, pp. 108–113, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. World Medical Association, “World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects,” JAMA, vol. 310, no. 20, pp. 2191–2194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Hegazy, R. M. A. Samie, A. Ezzat, N. Ramadan, L. A. Rashed, and A. M. ElSayed, “PNPLA3 and TNF-α G238A genetic polymorphisms in Egyptian patients with different grades of severity of NAFLD,” Open Journal of Gastroenterology, vol. 6, no. 3, pp. 53–64, 2016. View at Publisher · View at Google Scholar
  18. G. Tarantino, P. Colicchio, P. Conca et al., “Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively?” Journal of Inflammation, vol. 6, no. 1, p. 6, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global prevalence of diabetes: estimates for the year 2000 and projections for 2030,” Diabetes Care, vol. 27, no. 5, pp. 1047–1053, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Targher, C. P. Day, and E. Bonora, “Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease,” The New England Journal of Medicine, vol. 363, no. 14, pp. 1341–1350, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. A. J. McCullough, “Epidemiology of the metabolic syndrome in the USA,” Journal of Digestive Diseases, vol. 12, no. 5, pp. 333–340, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. A. de Piano, W. L. Prado, D. A. Caranti et al., “Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 44, no. 4, pp. 446–452, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. C. R. Kepler, W. P. Tucker, and S. B. Tove, “Biohydrogenation of unsaturated fatty acids. IV. Substrate specificity and inhibition of linoleate delta 12-cis, delta-11-trans-isomerase from Butyrivibrio fibrisolvens,” Journal of Biological Chemistry, vol. 245, no. 14, pp. 3612–3620, 1970. View at Google Scholar
  24. S. F. Chin, W. Liu, J. M. Storkson, Y. L. Ha, and M. W. Pariza, “Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens,” Journal of Food Composition and Analysis, vol. 5, no. 3, pp. 185–197, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. M. H. Cooper, J. R. Miller, P. L. Mitchell, D. L. Currie, and R. S. McLeod, “Conjugated linoleic acid isomers have no effect on atherosclerosis and adverse effects on lipoprotein and liver lipid metabolism in apoE−/− mice fed a high-cholesterol diet,” Atherosclerosis, vol. 200, no. 2, pp. 294–302, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. C. M. Reynolds and H. M. Roche, “Conjugated linoleic acid and inflammatory cell signalling,” Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 82, no. 4-6, pp. 199–204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. S. Choi, I.-U. Koh, M. H. Jung, and J. Song, “Effects of three different conjugated linoleic acid preparations on insulin signalling, fat oxidation and mitochondrial function in rats fed a high-fat diet,” British Journal of Nutrition, vol. 98, no. 2, pp. 264–275, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. L. Birkenfeld and G. I. Shulman, “Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes,” Hepatology, vol. 59, no. 2, pp. 713–723, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Greco, E. Chiefari, T. Montalcini et al., “Early effects of a hypocaloric, Mediterranean diet on laboratory parameters in obese individuals,” Mediators of Inflammation, vol. 2014, Article ID 750860, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. L. A. Adams, O. R. Waters, M. W. Knuiman, R. R. Elliott, and J. K. Olynyk, “NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study,” The American Journal of Gastroenterology, vol. 104, no. 4, pp. 861–867, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Hossain, A. Afendy, M. Stepanova et al., “Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease,” Clinical Gastroenterology and Hepatology, vol. 7, no. 11, pp. 1224–1229.e2, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Fritsche and H. Steinhart, “Analysis, occurrence, and physiological properties of trans fatty acids (TFA) with particular emphasis on conjugated linoleic acid isomers (CLA) - a review,” Lipid - Fett, vol. 100, no. 6, pp. 190–210, 1998. View at Publisher · View at Google Scholar
  33. L. D. Whigham, A. C. Watras, and D. A. Schoeller, “Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans,” The American Journal of Clinical Nutrition, vol. 85, no. 5, pp. 1203–1211, 2007. View at Publisher · View at Google Scholar
  34. H. Blankson, J. A. Stakkestad, H. Fagertun, E. Thom, J. Wadstein, and O. Gudmundsen, “Conjugated linoleic acid reduces body fat mass in overweight and obese humans,” The Journal of Nutrition, vol. 130, no. 12, pp. 2943–2948, 2000. View at Publisher · View at Google Scholar
  35. S. E. Steck, A. M. Chalecki, P. Miller et al., “Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans,” The Journal of Nutrition, vol. 137, no. 5, pp. 1188–1193, 2007. View at Publisher · View at Google Scholar
  36. A. Białek and A. Tokarz, “Conjugated linoleic acid as a potential protective factor in prevention of breast cancer,” Postępy Higieny i Medycyny Doświadczalnej, vol. 67, pp. 6–14, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. L. A. Smit, A. Baylin, and H. Campos, “Conjugated linoleic acid in adipose tissue and risk of myocardial infarction,” The American Journal of Clinical Nutrition, vol. 92, no. 1, pp. 34–40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Ebrahimi-Mameghani, H. Jamali, R. Mahdavi, F. Kakaei, R. Abedi, and B. Kabir-Mamdooh, “Conjugated linoleic acid improves glycemic response, lipid profile, and oxidative stress in obese patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial,” Croatian Medical Journal, vol. 57, no. 4, pp. 331–341, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. Z. Shadman, F. Taleban, N. Saadat, and M. Hedayati, “Effect of conjugated linoleic acid and vitamin E on glycemic control, body composition, and inflammatory markers in overweight type2 diabetics,” Journal of Diabetes & Metabolic Disorders, vol. 12, no. 1, p. 42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Venkatramanan, S. V. Joseph, P. Y. Chouinard, H. Jacques, E. R. Farnworth, and P. J. H. Jones, “Milk enriched with conjugated linoleic acid fails to alter blood lipids or body composition in moderately overweight, borderline hyperlipidemic individuals,” Journal of the American College of Nutrition, vol. 29, no. 2, pp. 152–159, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. I. J. Onakpoya, P. P. Posadzki, L. K. Watson, L. A. Davies, and E. Ernst, “The efficacy of long-term conjugated linoleic acid (CLA) supplementation on body composition in overweight and obese individuals: a systematic review and meta-analysis of randomized clinical trials,” European Journal of Nutrition, vol. 51, no. 2, pp. 127–134, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Kraft, M. Collomb, P. Möckel, R. Sieber, and G. Jahreis, “Differences in CLA isomer distribution of cow’s milk lipids,” Lipids, vol. 38, no. 6, pp. 657–664, 2003. View at Publisher · View at Google Scholar · View at Scopus